Depression in numbers

Depression in numbers

Depression is a relatively common condition that affects a large number of people globally.1 It is a mental disorder that comprises a constellation of emotional, physical and cognitive symptoms that often have a wider impact on patients’ friends, families, carers and employers.2

Depression is a global condition…

  • Depression affects in excess of 350 million people worldwide, and is estimated to become the leading cause of global disease burden by 20301,3
  • The estimated global cost of depression was more than $800 billion in 2010, and this is expected to at least double over the next two decades4
  • In Europe alone depression had a socioeconomic cost of nearly €54 billion in 2010 through loss of productivity and absence from the workplace5,6

affecting healthcare…

  • It has been estimated that up to 1 in 5 patients present with clinically significant depressive symptoms in primary care settings7
  • Physicians have been prescribing more antidepressants in recent decades. Studies have reported an increase in prescriptions ranging from 165% in England (between 1998 and 2012) to 400% in the USA (between 1988 and 2008)8,9
  • The cost of antidepressant prescriptions in 2011 reached £270 million in the UK, and $11 billion in the USA10,11

as well as individual patients.

  • People with depression are thought to be 20–40% more likely to be unemployed6
  • Patients with depression are 1.6 times more likely to develop heart disease than healthy individuals. That’s greater than the risk posed by passive smoking12
  • The risk of suicide in patients with depression is more than 20 times greater than the general population3

While a patient must present with either depressed mood or anhedonia to be diagnosed with depression, they may also be experiencing symptoms that impair their physical and/or cognitive functioning.2 The latter can have a devastating impact on their day-to-day lives but is often underestimated in clinical practice.2,13 The importance of cognition as a consideration of depression symptomatology, diagnosis and management is becoming increasingly apparent as the condition continues to affect more people each year.1,3

  1. Depression Factsheet. WHO. Available at: Accessed July 2015.
  2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Health Disorders. 5th Washington, DC: American Psychiatric Association; 2013.
  3. Lépine JP, Briley M. Neuropsychiatr Dis Treat 2011; 7(Suppl 1): 3–7.
  4. The World Bank. Mental Health. Available at: Accessed March 2017.
  5. Olesen J et al. Eur J Neurol 2012; 19(1): 155–162.
  6. Lerner D, Henke RM. J Occ Env Med 2008; 50(4): 401–410.
  7. Zung WW et al. J Farm Pract 1993; 37(4): 337–344.
  8. Spence R et al. PharmacoEconomics & Outcomes News 2014; 704(1): 2–7.
  9. Pratt LA et al. Antidepressant use in persons aged 12 and over: United States, 2005-2008. NCHS Data Brief No. 76. October 2011.
  10. Prescriptions Dispensed in the Community. England 2001-2011. Health and Social Care Information Centre, 2015.
  11. IMS Institute for Healthcare Informatics. The Use of Medicines in the United States: Review of 2011. April 2012.
  12. Chapman D et al. Prev Chronic Dis 2005; 2(1): A14.
  13. Jarema M et al. Psychiatr Pol 2014; 48(6): 1105–1116.
Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Register for access to Progress in Mind in your country